K
Keymedi
Medical platform for physicians and the healthcare industry
About Keymedi
Keymedi operates a comprehensive medical platform in South Korea, connecting physicians, hospitals, medical societies, and pharmaceutical companies. Founded by CEO Myeongjin Kim, the company aims to build a transparent and capable platform to improve the medical ecosystem.
The company's core services are divided into Medical Marketing & Sales Service (MMS) and Hospital Management Service (HMS). Under MMS, Keymedi offers "MEDI TV Live" for online medical seminars (webinars), "Brand Hall" for enhancing product and brand awareness among healthcare professionals, "MEDI TV Plus" for physician-curated broadcast services, and MICE (Meetings, Incentives, Conferences & Exhibitions) services for managing academic and corporate events both online and offline. The HMS division provides specialized, practical consulting for opening new clinics, particularly for dermatology, plastic surgery, and orthopedics, covering aspects like tax, legal, financing, interior design, and equipment. It also handles medical device distribution and HR services, including an AI-based physician recruitment solution called 'Keymatch'.
As of December 2023, the platform had over 45,000 registered users. Keymedi has established partnerships with organizations such as the Korean Pharmaceutical Cooperatives Association and the Korea Drug Research Association. The platform generates revenue by providing marketing solutions and management services to its corporate and hospital clients.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Sep 2023 | $22M | $86M | HLB Group | — |
Growth signals
Latest recorded traffic for Keymedi is 12K monthly website visits, up 179.1% over the last three months. Keymedi's team grew 0% over the past year.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
HLB Group
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Keymedi on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Keymedi’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.